These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14504198)

  • 1. Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.
    Stanford JL; Sabacan LP; Noonan EA; Iwasaki L; Shu J; Feng Z; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):876-81. PubMed ID: 14504198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPC2/ELAC2 gene variants associated with incident prostate cancer.
    Adler D; Kanji N; Trpkov K; Fick G; Hughes RM
    J Hum Genet; 2003; 48(12):634-638. PubMed ID: 14625808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
    Severi G; Giles GG; Southey MC; Tesoriero A; Tilley W; Neufing P; Morris H; English DR; McCredie MR; Boyle P; Hopper JL
    J Natl Cancer Inst; 2003 Jun; 95(11):818-24. PubMed ID: 12783937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.
    Xu B; Tong N; Li JM; Zhang ZD; Wu HF
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):270-7. PubMed ID: 20231859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HPC2/ELAC2 in hereditary prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer.
    Zahiri Z; Zahiri F
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1551-1557. PubMed ID: 32592348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.
    Fujiwara H; Emi M; Nagai H; Nishimura T; Konishi N; Kubota Y; Ichikawa T; Takahashi S; Shuin T; Habuchi T; Ogawa O; Inoue K; Skolnick MH; Swensen J; Camp NJ; Tavtigian SV
    J Hum Genet; 2002; 47(12):641-8. PubMed ID: 12522685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
    Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
    Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HPC2/ELAC2 genotypes and prostate cancer.
    Rebbeck TR; Walker AH; Zeigler-Johnson C; Weisburg S; Martin AM; Nathanson KL; Wein AJ; Malkowicz SB
    Am J Hum Genet; 2000 Oct; 67(4):1014-9. PubMed ID: 10986046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
    Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
    Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
    Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.
    Meitz JC; Edwards SM; Easton DF; Murkin A; Ardern-Jones A; Jackson RA; Williams S; Dearnaley DP; Stratton MR; Houlston RS; Eeles RA;
    Br J Cancer; 2002 Oct; 87(8):905-8. PubMed ID: 12373607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPC2 variants and screen-detected prostate cancer.
    Vesprini D; Nam RK; Trachtenberg J; Jewett MA; Tavtigian SV; Emami M; Ho M; Toi A; Narod SA
    Am J Hum Genet; 2001 Apr; 68(4):912-7. PubMed ID: 11254449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.
    Suarez BK; Gerhard DS; Lin J; Haberer B; Nguyen L; Kesterson NK; Catalona WJ
    Cancer Res; 2001 Jul; 61(13):4982-4. PubMed ID: 11431329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
    Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
    Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso.
    Traoré ADD; Ky BD; Traoré L; Zohoncon TM; Zouré AA; Yonli AT; Sombié HK; Sorgho PA; Elvira Bazié BVJT; Tovo SFA; Kadanga E; Bakyono BS; Traore K; Ouédraogo TC; Djigma FW; Simpore J
    Prostate Cancer; 2022; 2022():3610089. PubMed ID: 36643816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.
    Camp NJ; Tavtigian SV
    Am J Hum Genet; 2002 Dec; 71(6):1475-8. PubMed ID: 12515253
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.
    Chen YC; Giovannucci E; Kraft P; J Hunter D
    Carcinogenesis; 2008 May; 29(5):999-1004. PubMed ID: 18375959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.